Triose Phosphate Isomerase

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(Disease)
Line 3: Line 3:
{{STRUCTURE_1tim | PDB=1tim | SCENE= }}
{{STRUCTURE_1tim | PDB=1tim | SCENE= }}
- 
Line 20: Line 19:
-
=== Triose Phosphate Isomerase Deficiency ==
+
=== Triose Phosphate Isomerase Deficiency ===
-
 
+
Triose Phosphate Isomease Deficiency is a rare (less then 100 cases worldwide), autosomal recessive disorder first described in 1965.<Schneider, Arthur S.; William N. Valentine, Hattori M, H. L. Heins Jr (1965). "Hereditary Hemolytic Anemia with Triosephosphate Isomerase Deficiency". New England Journal of Medicine 272: 229–35> Symptoms include haemolytic anaemia, cardiomyopathy, an increased susceptibility to infections, severe neurological dysfunctions, and, often times, death in early childhood.
Triose Phosphate Isomease Deficiency is a rare (less then 100 cases worldwide), autosomal recessive disorder first described in 1965.<Schneider, Arthur S.; William N. Valentine, Hattori M, H. L. Heins Jr (1965). "Hereditary Hemolytic Anemia with Triosephosphate Isomerase Deficiency". New England Journal of Medicine 272: 229–35> Symptoms include haemolytic anaemia, cardiomyopathy, an increased susceptibility to infections, severe neurological dysfunctions, and, often times, death in early childhood.

Revision as of 22:30, 18 March 2009

Triose Phosphate Isomerase (TPI or TIM) which catalyzes the reversible interconversion of the triose phosphate isomers dihydroxyacetone phosphate and D-glyceraldehyde-3-phosphate, an essential process in the glycolytic pathway.


Template:STRUCTURE 1tim


Mechanism

Acid Base Catalysis

Image:TPI mechanism.jpg

Diagram .[1]

Personal tools